The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
Open accessAbstract
UNLABELLED: The purpose of this study was to assess the prognostic value of early (18)F-FDG PET using standardized uptake value (SUV) compared with visual analysis in patients with diffuse large B-cell lymphoma (DLBCL). METHODS: Ninety-two patients with newly diagnosed DLBCL underwent (18)F-FDG PET prospectively before and after 2 cycles of chemotherapy (at midtherapy). Maximum SUV (SUVmax) and mean SUV (SUVmean) normalized to body weight and body surface area, as well as tumor-to-normal ratios, were computed on the most intense uptake areas. The SUVs, tumor-to-normal ratios, and their changes over time were compared with visual analysis for predicting event-free survival (EFS) and overall survival, using receiver-operating-characteristic (ROC) analysis. Survival curves were estimated with Kaplan-Meier analysis and compared using the log-rank test. RESULTS: With visual analysis, the accuracy of early PET to predict EFS was 65.2%. The 2-y estimate for EFS was 51% (95% confidence interval [CI], 34%-68%) in the PET-positive group compared with 79% (95% CI, 68%-90%) in the PET-negative group (P = 0.009). An optimal cutoff value of 65.7% SUVmax reduction from baseline to midtherapy obtained from ROC analysis yielded an accuracy of 76.1% to predict EFS. The 2-y estimate for EFS was 21% (95% CI, 0%-42%) in patients with SUVmax reduction 65.7% (P < 0.0001). Fourteen patients considered as positive on visual analysis could have been reclassified as good responders. CONCLUSION: SUV-based assessment of therapeutic response during first-line chemotherapy improves the prognostic value of early (18)F-FDG PET compared with visual analysis in DLBCL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size
Hoffman, E. J., Huang, S.-C., & Phelps, M. E. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197906000-00001 · Cited by 1,143
SUV: standard uptake or silly useless value?
Keyes, J. W. (1995) · PubMed · Cited by 803
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
(2004) · PubMed · Cited by 653
Jerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Understanding the standardized uptake value, its methods, and implications for usage.
Thie, J. A. (2004) · PubMed · Cited by 546
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Self-citationSchöder, H., Noy, A., Gönen, M., Weng, L., Green, D., Erdi, Y. E., Larson, S. M., & Yeung, H. W. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.072 · Cited by 491
Huang, (. S.-C. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00155-4 · Cited by 458
Huang, S.-C., Hoffman, E. J., Phelps, M. E., & Kuhl, D. E. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197912000-00018 · Cited by 443
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Römer, W., Hanauske, A.-R., Ziegler, S. I., Thödtmann, R., Weber, W., Fuchs, C., Enne, W., Herz, M., Nerl, C., Garbrecht, M., et al. (1998) · PubMed · doi:10.1182/blood.v91.12.4464 · Cited by 335
Gallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., Iannitto, E., et al. (2006) · PubMed · Cited by 314
Sugawara, Y., Zasadny, K. R., Neuhoff, A. W., & Wahl, R. L. (1999) · Radiology · doi:10.1148/radiology.213.2.r99nv37521 · Cited by 265
Hoekstra, C. J., Paglianiti, I., Hoekstra, O. S., Smit, E. F., Postmus, P. E., Teule, G. J. J., & Lammertsma, A. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050570 · Cited by 251
Mikhaeel, N. G., Timothy, A. R., O’Doherty, M. J., Hain, S. F., & Maisey, M. N. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009113384 · Cited by 248
Quantitation in Positron Emission Computed Tomography: 4. Effect of Accidental Coincidences
Hoffman, E. J., Huang, S.-C., Phelps, M. E., & Kuhl, D. E. (1981) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198106000-00015 · Cited by 227
Jerusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000) · PubMed · Cited by 203
Kostakoğlu, L., & Goldsmith, S. J. (2003) · PubMed · Cited by 172
Comparison of simplified quantitative analyses of FDG uptake
Graham, M. M., Peterson, L. M., & Hayward, R. M. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00143-8 · Cited by 169
FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls
Kazama, T., Faria, S. C., Varavithya, V., Phongkitkarun, S., Ito, H., & Macapinlac, H. A. (2005) · Radiographics · doi:10.1148/rg.251045045 · Cited by 145
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
Tatsumi, M., Cohade, C., Nakamoto, Y., Fishman, E. K., & Wahl, R. L. (2005) · Radiology · doi:10.1148/radiol.2373040555 · Cited by 138
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma
Torizuka, T., Nakamura, F., Kanno, T., Futatsubashi, M., Yoshikawa, E., Okada, H., Kobayashi, M., & Ouchi, Y. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1333-8 · Cited by 107
Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay, C., Lépine, M., Verreault, J., & Bénard, F. (2003) · PubMed · Cited by 105
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon, Y. L., Jones, R. J., & Wahl, R. L. (2007) · PubMed · Cited by 101
YEUNG, H. W. D., Sanches, A., Squire, O. D., Macapinlac, H. A., Larson, S. M., & Erdi, Y. E. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0662-8 · Cited by 67
Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
Yamane, T., Daimaru, O., Ito, S., et al. (2004) · PubMed · Cited by 54
MRI and PET in monitoring response in lymphoma
Rahmouni, A. (2005) · Cancer Imaging · doi:10.1102/1470-7330.2005.0038 · Cited by 29
Self-citationJérusalem, G., & Beguin, Y. P. (2006) · PubMed · Cited by 19
Cited by
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
“9% accuracy in outcome prediction) (86).”
BackgroundResultInfluentialBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Self-citationPredicting cancer outcomes with radiomics and artificial intelligence in radiology
Bera, K., Braman, N., Gupta, A., Velcheti, V., & Madabhushi, A. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00560-7 · Cited by 819
18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
Weiler-Sagie, M., Bushelev, O., Epelbaum, R., Dann, E. J., Haim, N., Avivi, I., Ben-Barak, A., Ben-Arie, Y., Bar-Shalom, R., & Israel, O. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067892 · Cited by 382
A review on segmentation of positron emission tomography images
Foster, B., Bagci, U., Mansoor, A., Xu, Z., & Mollura, D. J. (2014) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2014.04.014 · Cited by 370
Metadata
- Authors
- Lin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2007-10-01
- Volume
- 48
- Issue
- 10
- Pages
- 1626-1632
- ISSN
- 0161-5505 (ISSN-L)
- OpenAlex
- W2138384559
- Cited by
- 394
- References
- 33
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.